Zuranolone for postpartum depression: a systematic review and meta-analysis of two randomized studies
Abstract Objective: To evaluate the maternal outcomes in women with postpartum depression using zuranolone, the first oral medication indicated to treat postpartum depression. Methods: We conducted a systematic search in September 2023, on Pubmed, Embase and Cochrane Trials. We included randomized...
Saved in:
Main Authors: | Juliana Almeida Oliveira, Karine Eskandar, Marcos Aurélio Araújo Freitas, Chris Elizabeth Philip |
---|---|
Format: | Article |
Language: | English |
Published: |
Federação Brasileira das Sociedades de Ginecologia e Obstetrícia
2025-01-01
|
Series: | Revista Brasileira de Ginecologia e Obstetrícia |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-72032024000100321&lng=en&tlng=en |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Utility of Zuranolone for Postpartum Depression: A Narrative Review
by: Giannopoulos A, et al.
Published: (2025-01-01) -
Treatment of Postpartum Depression with Neurosteroids
by: Reda Stankevičiūtė, et al.
Published: (2024-03-01) -
Evaluation of Prevalence and Risk Factors for Postpartum Depression Using the Edinburgh Postpartum Depression Scale: A Cross-Sectional Analytic Study
by: Gaye Kahveci, et al.
Published: (2021-12-01) -
Postpartum depression in relation to chronic diseases and multimorbidity in women’s mid-late life: a prospective cohort study of UK Biobank
by: Yue Zhang, et al.
Published: (2025-01-01) -
Efficacy and safety of ketamine and esketamine in reducing the incidence of postpartum depression: an updated systematic review and meta-analysis
by: Moaz Yasser Darwish, et al.
Published: (2025-02-01)